BioSpace News Archive

Under the terms of the agreement, Pfizer will combine its consumer healthcare business with GSK’s existing consumer healthcare business. The combined global sales were about $12.7 billion last year. Closing is expected in the second half of 2019, dependent on GSK’s shareholder approval and regulatory approvals.

-- Colin Freund has joined as CEO; Dr. Edwin De Wit appointed Head of Oncology Development --

Collaboration to evaluate combination of APG-115, Ascentage’s MDM2-p53 inhibitor and genolimzumab, Genor’s anti-PD-1 monoclonal antibody in solid tumors and blood cancers

Dr. Tarik Hadid Provides Comprehensive and Personalized Oncology Care in Detroit and Warren, MI

Today announced that it completed a Pre-Submission (Pre-Sub) meeting with the US FDA on December 17, 2018.

Under the terms of the agreement, Roivant will have the option to obtain exclusive licenses for certain development programs from Daiichi Sankyo on prespecified terms contingent on phase of development.

Sutro develops successful spray drying technology marking a major advancement in commercial-scale manufacturing capabilities

National non-medical home care provider expanding California presence

Acorda’s President and CEO, will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 9 at 8:00am PST / 5:00am EST.

Two studies to evaluate ARY-007 in combination with KEYTRUDA® (pembrolizumab) in checkpoint-resistant solid tumors